| Income Statement | 2026-04-24 | |||
|---|---|---|---|---|
| Net sales | 3,102 | |||
| Cost of products sold | 1,422 | |||
| Gross profit | 1,680 | |||
| Research and development expense | 448 | |||
| Selling, general, and administrative expense | 1,183 | |||
| Certain litigation charges, net | -18 | |||
| Other operating expense (income), net | -221 | |||
| Operating loss | -190 | |||
| Other non-operating expense (income), net | 1 | |||
| Loss before income taxes | -189 | |||
| Income tax provision | 128 | |||
| Net loss | -317 | |||
| Net income attributable to noncontrolling interests | 16 | |||
| Net loss attributable to the company | -333 | |||
| Basic EPS | -1.3 | |||
| Diluted EPS | -1.3 | |||
| Basic Average Shares | 256,600,000 | |||
| Diluted Average Shares | 256,600,000 | |||
MiniMed Group, Inc. (MMED)
MiniMed Group, Inc. (MMED)